Hypertension in Turner syndrome: a review of proposed mechanisms, management and new directions
Article 2022 en
Authors
LJ
Lily Jones
JB
Joanne Blair
DH
Daniel B. Hawcutt
Abstract
1 min read
Acquired cardiovascular diseases account for much of the increased risk of premature death in patients with Turner syndrome (TS). Hypertension is a major modifiable cardiovascular risk factor. It has a high prevalence in TS developing at an early age and thus leading to prolonged exposure to high blood pressure. The aetiology for hypertension in TS is largely unknown. It is likely multifactorial, and recent hypotheses include altered sympathetic tone, vasculopathy and endocrine factors. In this review article we aim to provide a comprehensive review of data on mechanisms of hypertension in TS and their implication for diagnostics and optimal choice of antihypertensive treatments. Ultimately this knowledge should help prevent hypertension-related complications, and improve quality of life and life expectancy for patients with TS.
Lucas Lauder, Felix Mahfoud, Michel Azizi, Deepak L. Bhatt, Sebastian Ewen, Kazuomi Kario, Gianfranco Parati, Patrick Rossignol, Markus P. Schlaich, Koon Teo, Raymond R. Townsend, Costas Tsioufis, Michael A. Weber, Thomas Weber, Michael Böhm
Teemu Niiranen, Renate B. Schnabel, Aletta E. Schutte, Yitschak Biton, Giuseppe Boriani, Claire Buckley, Alan C. Cameron, Albertino Damasceno, Søren Zöga Diederichsen, Wolfram Doehner, Yutao Guo, Richard Hobbs, Boyoung Joung, Graeme J. Hankey, Professor Gregory Lip, Trudie Lobban, Maja‐Lisa Løchen, Georges H. Mairesse, Amam Mbakwem, Peter A. Noseworthy, George Ntaios, Steven R. Steinhubl, George S. Stergiou,
Discussion(0)
No comments yet. Be the first to comment.